This sounds incredible and I really hope mRNA doesn't end up being the Graphene of this decade (the fact that it's already used in the biggest "mass market" pro

This sounds incredible and I really hope mRNA doesn't end up being the Graphene of this decade (the fact that it's already used in the biggest "mass market" product imaginable suggests it won't be). My question for people that know more about this stuff – do we need to tweak our regulatory framework for therapeutics like this one that are extremely laser focused? When you are literally targeting a specific RNA code, the chances of side effects should be pretty minimal in general, correct? Or is the fact that all this kind of immunotherapy still too new, require the same amount of oversight?